Morning @stardestr0yer in one of the recent presentations Sam alerts to a $25m order received with more clients signing up weekly.
My personal belief is BXN will over deliver in the next Qtr and exceed previous forecasts...
Also they are the only Company to have a license in Australia to produce synthetic MDMA and Psilocybin this is also at GMP grade for use in Trials and in Lab Testing...
SP still has a way to go just to play catch up from falling from the 9c range with the Trump Tariff Tantrum and the new Czech plant is to supply Europe and the UK so no Tariff impact...
Nice to see some SH Value being restored yesterday ,,NZT
BXN Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)